MDT

86.64

+1.07%↑

A

113.82

+1.66%↑

VEEV

175.34

+0.03%↑

HQY

83.66

+3.08%↑

CSBR

5.7

+2.52%↑

MDT

86.64

+1.07%↑

A

113.82

+1.66%↑

VEEV

175.34

+0.03%↑

HQY

83.66

+3.08%↑

CSBR

5.7

+2.52%↑

MDT

86.64

+1.07%↑

A

113.82

+1.66%↑

VEEV

175.34

+0.03%↑

HQY

83.66

+3.08%↑

CSBR

5.7

+2.52%↑

MDT

86.64

+1.07%↑

A

113.82

+1.66%↑

VEEV

175.34

+0.03%↑

HQY

83.66

+3.08%↑

CSBR

5.7

+2.52%↑

MDT

86.64

+1.07%↑

A

113.82

+1.66%↑

VEEV

175.34

+0.03%↑

HQY

83.66

+3.08%↑

CSBR

5.7

+2.52%↑

Search

Quanterix Corp

Deschisă

SectorSănătate

3.54 4.73

Rezumat

Modificarea prețului

24h

Curent

Minim

3.35

Maxim

3.76

Indicatori cheie

By Trading Economics

Venit

10M

-23M

Vânzări

3.7M

44M

Marjă de profit

-52.712

Angajați

450

EBITDA

15M

-17M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+109.5% upside

Dividende

By Dow Jones

Următoarele câștiguri

11 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-111M

185M

Deschiderea anterioară

-1.19

Închiderea anterioară

3.54

Sentimentul știrilor

By Acuity

50%

50%

169 / 349 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

30 mar. 2026, 23:15 UTC

Evenimente importante

U.K. Shoppers Paid a Little More This Month But Worse May yet Lie Ahead

30 mar. 2026, 22:36 UTC

Evenimente importante

Australian Government Rules Out Boots on the Ground in the Middle East

30 mar. 2026, 22:13 UTC

Achiziții, Fuziuni, Preluări

Sun Life Financial Agrees to Buy Bell Partners for $350 Million

30 mar. 2026, 21:00 UTC

Câștiguri

Aktis Oncology Gets FDA Clearance for Phase 1 Billion Trial of Tumor Treatment

30 mar. 2026, 20:15 UTC

Evenimente importante

Fed's Williams: Middle-East Developments Have Added Significant Economic Uncertainty

30 mar. 2026, 23:40 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

30 mar. 2026, 23:40 UTC

Market Talk

Nikkei May Decline on Higher Energy Cost Concerns -- Market Talk

30 mar. 2026, 23:36 UTC

Market Talk

Gold Edges Lower Amid Divergent Signals on U.S.-Iran Talks -- Market Talk

30 mar. 2026, 23:12 UTC

Market Talk

Alcoa Earnings Outlook Boosted by Market Disruptions -- Market Talk

30 mar. 2026, 22:49 UTC

Market Talk

Fed's Williams: Core Inflation Forecast Is Little Changed -- Market Talk

30 mar. 2026, 22:44 UTC

Market Talk

Fed's Williams: Risks to Both Sides of Dual Mandate Higher -- Market Talk

30 mar. 2026, 22:43 UTC

Market Talk

Fed's Williams Says Focus Is on Inflation Expectations Being Well Anchored -- Market Talk

30 mar. 2026, 22:42 UTC

Market Talk

South32 Should Go for Growth, Says New Bull -- Market Talk

30 mar. 2026, 22:18 UTC

Market Talk

Paragon Care's Chances of Using Levy to Pass on Higher Costs `Close to Zero' -- Market Talk

30 mar. 2026, 22:05 UTC

Market Talk

Northern Star's New Bull Argues Case for Asset Sales -- Market Talk

30 mar. 2026, 21:58 UTC

Achiziții, Fuziuni, Preluări

Sun Life Financial Agrees to Buy Bell Partners for $350M

30 mar. 2026, 21:39 UTC

Achiziții, Fuziuni, Preluări

Sun Life Sees 1Q Charge to Net of C$236M From BGO, Crescent Deals

30 mar. 2026, 21:38 UTC

Achiziții, Fuziuni, Preluări

Sun Life: Completes Remaining Equity Interest Purchases of BGO, Crescent Capital

30 mar. 2026, 21:36 UTC

Achiziții, Fuziuni, Preluări

Sun Life to Buy Fully Bell Partners for $350M >SLF.T

30 mar. 2026, 21:33 UTC

Achiziții, Fuziuni, Preluări

Unilever Shareholders Expected to Own Two-Thirds of New Food Entity, Sources Say -- WSJ

30 mar. 2026, 21:33 UTC

Achiziții, Fuziuni, Preluări

Unilever Nears Deal to Create $60 Billion Food Giant With McCormick -- WSJ

30 mar. 2026, 21:33 UTC

Achiziții, Fuziuni, Preluări

Deal Could Be Announced As Soon As Tuesday, Sources Say -- WSJ

30 mar. 2026, 21:33 UTC

Achiziții, Fuziuni, Preluări

Unilever Nears Cash-and-Stock Deal to Combine Food Business With McCormick, Sources Say -- WSJ

30 mar. 2026, 21:33 UTC

Achiziții, Fuziuni, Preluări

Deal Set to Value Combined Food Business At Around $60B Including Debt, Sources Say -- WSJ

30 mar. 2026, 21:25 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

30 mar. 2026, 21:25 UTC

Market Talk

Warehouse Showing Cost Discipline But Margin Goal at Risk -- Market Talk

30 mar. 2026, 21:03 UTC

Achiziții, Fuziuni, Preluări

Sun Life: Completes Equity Interest Purchases of BGO and Crescent Cap, Announces Acquisition of Bell Partners, a Multifamily Real Estate Investment Manager

30 mar. 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

30 mar. 2026, 20:09 UTC

Câștiguri

This Stock Looks Like a Solid AI Bet -- and Wall Street Hasn't Noticed Yet -- Barrons.com

30 mar. 2026, 20:00 UTC

Evenimente importante

Fed's Williams: Middle-East Conflict 'Will Likely Boost Overall Inflation in Coming Months'

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

109.5% sus

Prognoză pe 12 luni

Medie 7.5 USD  109.5%

Maxim 8 USD

Minim 7 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

169 / 349 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat